S100A8 and ovarian carcinoma: Overexpression of S100A8 in breast cancer (57), ovarian cancer (58), liver cancer (59), acute myeloid leukemia (60), and melanoma (12), suggests its increased expression has been associated with tumor growth, invasion, and metastasis (16, 28).